New method to assess the pozzolanic reactivity of mineral admixtures by means of pH and electrical conductivity measurements in lime:pozzolan suspensions

A very simple method based on electrical conductivity and pH measurements was proposed for assessing reactivity of pozzolans. Calcium hydroxide: pozzolan water suspensions were monitored by means of measurements of electrical conductivity and pH values. In these suspensions, Ca(OH)(2) in solid state was initially present, being them, thus, saturated in this reagent. Three testing temperatures were selected (40, 50 and 60 degrees C). In the experiments carried out, calcium hydroxide was suspended in deionized water for yielding a lime saturated suspension. The addition of siliceous pozzolan (two types of rice husk ash RHA and two types of densified silica fume DSF were tested) to the saturated lime suspension can produce the unsaturation of the system, depending on the testing time, testing temperature and reactivity of pozzolan. When unsaturation was reached, the loss of electrical conductivity was higher than 30% and the variation of pH was higher than 0.15 units. These threshold values were selected for characterizing the reactivity of pozzolans by means of a proposed template, classifying the pozzolan in three different reactivity levels.

Role of the clinical pharmacist in detection of drug therapy problemas in critically impatients: experience report

This is an experience report on clinical pharmacy in New York, United States of America, in a teaching hospital, describing the results of drug therapy monitoring in critically ill patients, as well as interventions to solve or prevent identified drug therapy problems. The cross-sectional study was conducted by the clinical staff at the Surgical Intensive Care Unit during August 20th to 24th, 2012. Blood counts, serum levels of certain antibiotics, microbiological cultures and their antibiotic susceptibility, possible drug interactions, dosage of each drug prescribed and the compatibility between the route of administration and pharmaceutical form were assessed daily through review of electronic medical records. Twenty seven patients were followed up and 16 drug therapy problems were identified: Unnecessary drug therapy (seven), adverse drug reaction (four), needs additional drug therapy (two), noncompliance (two) and dosage too low (one). After evaluation, the drug therapy problems and their pharmaceutical interventions were reported to clinical pharmaceutical responsible for the Surgical ICU, as well as the multidisciplinary team. Further, the clinical outcomes were monitored and interventions were classified as to its acceptance. Data demonstrate that clinical pharmacists can contribute to the security and proper use of medications, as the trigger tools for intensive monitoring helps in early detection of drug therapy problems and patient safety.